Physician profile
Nicholas Cappa
NPI 1588124796
$13,902.92
in general payments reported to CMS, 2019-2025
34 companies · $1,550 in 2025
The $1,550 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $285 · 2022: $1,420 · 2023: $6,134 · 2024: $4,513 · 2025: $1,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,489 · Travel and Lodging: $5,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,489.29 |
| Travel and Lodging | $5,708.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,774.67 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $2,409.27 | 2023-2025 | Grafix, Stravix Pl, Oasis |
| Stryker Corporation | $2,074.14 | 2022-2025 | Prostep, Augment Injectable, Dart-Fire |
| Arthrex, INC. | $977.70 | 2024 | |
| Paratek Pharmaceuticals, INC. | $585.72 | 2022-2025 | Nuzyra |
| Gotham Surgical Solutions & Devices, INC. | $545.94 | 2023-2024 | |
| Abbvie INC. | $509.99 | 2022-2025 | Dalvance |
| Organogenesis INC. | $433.69 | 2023-2025 | Puraply Wound Matrix, Apligraf, Puraply |
| Next Science LLC | $411.38 | 2023-2024 | Blastx, Xperience, Surgx |
| Bone Support INC. | $281.97 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $275.00 | 2021-2022 | |
| Treace Medical Concepts, INC. | $247.65 | 2022-2025 | |
| Heron Therapeutics, INC. | $247.40 | 2021-2022 | |
| Kci USA, INC. | $238.04 | 2022-2023 | V.A.C. Dermatac, V.A.C. Veraflo, V.A.C.Ulta |
| Bioventus LLC | $224.31 | 2023 | Theragenesis Bilayer Wound Matrix |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $220.34 | 2024 | |
| Polynovo North America LLC | $193.15 | 2024-2025 | Novosorb Btm |
| Solventum Corporation | $158.25 | 2024 | Activ.A.C., V.A.C. Dermatac, V.A.C.Ulta |
| Paragon 28, INC. | $143.30 | 2024-2025 | Precision Mis Bunion |
| Lifenet Health | $139.61 | 2025 | Theragenesis Wound Matrix |
| Horizon Therapeutics Plc | $137.68 | 2021 | |
| Nevro Corp. | $135.38 | 2022 | |
| Medtronic, INC. | $133.39 | 2023-2024 | Intellis Adaptivestim |
| Grt US Holding, INC. | $102.24 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $56.43 | 2025 | Caldolor |
| Reprise Biomedical, INC. | $47.06 | 2024-2025 | Miro3d |
| Baxter Healthcare | $39.52 | 2022 | |
| Averitas Pharma INC. | $31.56 | 2024 | Qutenza |
| Melinta Therapeutics, LLC | $23.58 | 2023 | Orbactiv, Kimyrsa |
| Pacira Pharmaceuticals Incorporated | $23.48 | 2022 | |
| Biocomposites INC | $21.98 | 2025 | Stimulan |
| Urgo Medical North America, LLC | $20.80 | 2025 | Urgoclean Ag |
| Sebela Pharmaceuticals INC. | $20.69 | 2023 | Pramosone, Naftin |
| Mimedx Group, INC. | $17.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Cappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.